Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone

P Mikosch1

  • 11st Medical Department, Hanusch Hospital, Vienna, Austria. peter.mikosch@tele2.at

Insights

Gaucher disease (GD) causes bone problems like pain and fractures. Current treatments, including enzyme replacement and substrate reduction therapy, improve bone health and reduce symptoms in patients with this genetic disorder.

Area of Science:

  • Genetics and Genetic Diseases
  • Metabolic Diseases
  • Hematology

Background:

  • Gaucher disease (GD) is an inherited lysosomal storage disorder impacting multiple organs.
  • Non-neuronopathic GD, the most common type, presents with various symptoms including hepatosplenomegaly, anemia, and skeletal issues.
  • Bone manifestations in GD are significant, encompassing infarcts, avascular necrosis, osteosclerosis, fractures, and osteomyelitis, severely affecting patient morbidity.

Purpose of the Study:

  • To provide a comprehensive overview of bone pathologies in Gaucher disease.
  • To discuss the pathophysiology, diagnostics, and clinical management of GD bone manifestations.
  • To evaluate the therapeutic effects of enzyme replacement therapy (ERT), substrate reduction therapy (SRT), and bone-specific treatments on GD bone disease.

Main Methods:

  • Review of existing literature on Gaucher disease bone pathology.
  • Analysis of clinical data regarding diagnostic approaches.
  • Assessment of therapeutic outcomes from ERT, SRT, and other relevant treatments.

Main Results:

  • Available therapies like ERT and SRT rapidly improve hematological and visceral symptoms in GD.
  • These therapies also demonstrate beneficial effects on bone pain, bone crises, and osteoporosis progression.
  • The article details the pathophysiology and diagnostic criteria for GD bone complications.

Conclusions:

  • Gaucher disease significantly impacts bone health, leading to pain, fractures, and reduced quality of life.
  • Enzyme replacement therapy and substrate reduction therapy offer significant benefits for bone manifestations in GD.
  • Further focus on bone-specific therapies alongside current treatments is crucial for comprehensive GD management.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
The Functions of the Skeletal System01:22

The Functions of the Skeletal System

The most apparent functions of the skeletal system are support, protection, and movement. However, bone tissue also performs several other critical metabolic functions. For one, the bone matrix acts as a reservoir for a number of minerals important to the functioning of the body, especially calcium and phosphorus. These minerals, present in the bone tissue, can be released back into the bloodstream when required. Calcium ions, for example, are essential for muscle contractions and controlling...
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...